RxDoctor Payments Data

Benjamin Swanson, MD

Family Medicine · Greenwood, SCNPI 1528564135

Payments from drug & device makers

$1,768in general payments, 2019–2025

Across 93 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$253
  • AbbVie$229
  • Lilly USA, LLC$181
  • Merck$156
  • Novo Nordisk$134
  • Viiv Healthcare Company$121
  • plus $695 from 15 others

What the payments were for

  • Food & beverage$1,768100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,768 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$864
Medicare patients
26
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol65$50,986
MounjaroTirzepatide31$43,491
OzempicSemaglutide44$38,664
JardianceEmpagliflozin29$36,789
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$21,716
Xigduo XrDapaglifloz Propaned/Metformin28$17,149
XareltoRivaroxaban14$15,665
Spiriva HandihalerTiotropium Bromide22$13,309
Janumet XrSitagliptin Phos/Metformin Hcl16$11,308
Synjardy XrEmpagliflozin/Metformin Hcl12$9,410
MyrbetriqMirabegron11$9,250
LinzessLinaclotide16$8,389
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$5,568
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$4,199
ShingrixVaricella-Zoster Ge/As01b/Pf16$3,602

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$253$50,98665 claims
Lilly USA, LLCMounjaro$181$43,49131 claims
Novo NordiskOzempic$134$38,66444 claims
GSKTrelegy Ellipta, Shingrix$42$25,31835 claims
Johnson & JohnsonXarelto$16$15,66514 claims
MerckJanumet Xr$156$11,30816 claims
AbbVieLinzess$229$8,38916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Greenwood

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →